Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > Watch Dopesick on Disney Plus
View:
Post by Forestview on Jan 03, 2023 11:19am

Watch Dopesick on Disney Plus

Hey all, happy new year.  Like many of you, I took the time to binge watch some TV over the holidays.  One show I recommend all of you to watch is Dopesick, based on Purdue Pharma's development of OxyContin, and how its highly addictive nature (which Purdue grossly downplayed) decimated the lives of tens of thousands of people.  If anyone wonders what ATE is doing, and the potential impact it may have on the world, this series will reinforce its importance.  

I hope ATE continues to make progress in 2023, there is a real, tangible market for Otena, and others.  

Good luck longs.
Comment by MrMugsy on Jan 03, 2023 1:43pm
hahaha - well said Forestview. I know the story of Purdue but I'm sure there is a lot more information in Dopesick. Will be watching !!! 2 million Americans (every year) "may" fall into the opioid trap after surgery.  We have to get away from them.  Similarly we need to get away from NSAIDs and bleeding ulcers. I will be putting out a few tid-bits about ATE in 2023 as per ...more  
Comment by baggerx99 on Jan 03, 2023 8:33pm
Link to wedinar, definate worth a listen, re-listen..... https://www.youtube.com/watch?v=5_M2ucaYGoQ&t=37s
Comment by MrMugsy on Jan 04, 2023 1:46am
Exactly right Bagger ... It takes a few listens to really get all the details. One comment that Dan made that really got me thinking was ... lots of H2S learning over the past 3 years which adds to our understanding and intelectual property. That comment may relate directly to the improved understanding of our drug, how it affect the liver - and - the move to amorphous OTENA ... but ... there ...more  
Comment by baggerx99 on Jan 04, 2023 9:45pm
Some takeaways from webinar..... Otena....transitioning to acute market, confidence that they won't see toxicity issue....eliminating duration issues, acute regiment of 5-6 days targeting urgent need of rapid onset of pain relief in 60 minutes with better formulation opportunity super strong pain killer weekly phone calls from biotech wanting to merge Never been in a lesser risk point ...more  
Comment by MrMugsy on Jan 05, 2023 5:03pm
Yes Bagger. Now think about the patents for a moment. We knew there was going to be opportunity to get the IP to 20 years. But there's much more to the IP game. It's the gift that keeps on giving ... 1.  The initial layer of IP is the "composition of matter" patent. 2.  The next layer on top of that is "regime" related.  There will be one regime for ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities